临床验证显示qSOFA与床旁乳酸贝叶斯模型一致性良好:ACDC二期项目结果
本研究为ACDC二期项目的两部分验证:第一部分用院前乳酸荟萃分析数据构建贝叶斯模型,将qSOFA评分与床旁乳酸整合计算后验概率;第二部分为回顾性观察性临床验证,纳入2016至2017年急诊诊断脓毒症患者。贝叶斯模型中院前乳酸阳性似然比1.69、阴性似然比0.44,整合qSOFA后后验概率显著改善。临床验证纳入1470例,其中176例符合分析标准;qSOFA联合异常乳酸与qSOFA联合正常乳酸相比,ICU与非ICU队列差异有统计学意义(P<0.01),OR 2.35(95%CI 1.22-4.6)。作者结论认为qSOFA临床决策可由床旁乳酸辅助补充。
要点
- 贝叶斯模型中院前乳酸阳性似然比1.69、阴性似然比0.44,与qSOFA整合后后验概率显著改善。
- 临床验证中qSOFA联合异常乳酸与qSOFA联合正常乳酸相比,ICU与非ICU队列差异有统计学意义(P<0.01),OR 2.35(95%CI 1.22-4.6)。
- 临床验证纳入2016至2017年急诊诊断脓毒症患者1470例,其中176例符合分析标准。
- 作者认为基于qSOFA的临床决策可由床旁乳酸辅助补充,贝叶斯模型结果获临床验证支持。
适用人群与场景
- 急诊诊断脓毒症患者,数据来自2016至2017年。
- 临床验证共纳入1470例,其中176例符合分析标准。
诊断标准与关键阈值
- 使用qSOFA评分计算验前概率,结合院前乳酸插入贝叶斯模型计算后验概率。
- 院前乳酸荟萃分析数据:阳性似然比1.69,阴性似然比0.44。
研究设计与关键结果
- 研究为两部分验证设计:贝叶斯建模臂与回顾性观察性临床验证臂。
- 贝叶斯建模臂:院前乳酸荟萃分析阳性似然比1.69、阴性似然比0.44,整合qSOFA后后验概率显著改善。
- 临床验证臂:纳入1470例急诊脓毒症患者,176例符合分析标准。
- qSOFA联合异常乳酸与qSOFA联合正常乳酸比较,ICU与非ICU队列差异有统计学意义(P<0.01),OR 2.35(95%CI 1.22-4.6)。
证据类型、等级与局限
- 证据类型:贝叶斯建模结合回顾性观察性临床验证。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为基于qSOFA的临床决策可由床旁乳酸辅助补充。
- 临床验证显示qSOFA联合异常乳酸与ICU入住相关(OR 2.35,95%CI 1.22-4.6)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: Sepsis is a common and lethal medical problem. The objective of this study was to validate a Bayesian Model that integrates qSOFA and prehospital Lactate, with a comparison analysis from a real clinical data of patients with sepsis.
METHODS: We conducted a two tired validation study with one arm focusing on Bayesian modeling and a second retrospective observational arm addressing real data validation. For Bayesian modeling, sensitivity and specificity of prehospital lactate were attained from pooled meta-analysis data. Later, for clinical validation, we used data from 2016 to 2017 of ED patients diagnosed with sepsis. Pretest probabilities from qSOFA score where combined with prehospital lactate and inserted into a Bayesian model to calculate posttest probabilities. Absolute and relative diagnostic gains were calculated. Statistical significance was assessed via t-test, chi square and odds ratio. P value was set to be 0.05.
RESULTS: For the Bayesian arm; meta-analysis data for prehospital lactate resulted in a positive likelihood ratio (LR+) of 1.69 and negative likelihood ratio (LR-) of 0.44. Integration of lactate and qSOFA demonstrated significant post-test improvements. On the Clinical Validation arm, 1470 patients were included with 176 patients meeting analysis criteria. When comparing qSOFA + Abnormal Lactate vs qSOFA and normal Lactate, the ICU vs Non-ICU cohorts were statistically different (p < 0.01) Odds Ratio: 2.35 (95% CI [1.22-4.6]).
CONCLUSION: Bayesian mathematical model demonstrated that a qSOFA-based clinical decision can be complemented by the use of point of-care lactate. These results were confirmed by our clinical validation arm.
参考来源
- Báez AA, López O, Martínez MDP, et al. Clinical validation demonstrates concordance of qSOFA and POC lactate Bayesian model: Results from the ACDC Phase-2 program. Am J Emerg Med. 2020. PMID: 33046312. doi:10.1016/j.ajem.2020.09.080
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。